Integralni membranski protein kodiran ovim genom pripada grupi EDG receptora. Ti receptori su članovi familije G protein spregnutih receptora. EDG receptori posreduju različite bioločkie funkcije, uključujući proliferaciju, agregaciju trombocita, kontrakcije glatkih mišića, inhibiciju diferencijaciju neuroblastomnih ćelija, hemotaksu, i invaziju tumornih ćelija. Alternativno splajsovanje ovog gena je uočeno i dve transkriptne varijante su opisane. One kodiraju identične proteine.[1]
↑An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ (February 1997). „Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid”. Biochem. Biophys. Res. Commun.231 (3): 619–22. DOI:10.1006/bbrc.1997.6150. PMID9070858.
An S, Goetzl EJ, Lee H (1999). „Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.”. J. Cell. Biochem. Suppl.30-31: 147–57. PMID9893266.
Contos JJ, Ishii I, Chun J (2001). „Lysophosphatidic acid receptors.”. Mol. Pharmacol.58 (6): 1188–96. PMID11093753.
An S, Bleu T, Zheng Y, Goetzl EJ (1998). „Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.”. Mol. Pharmacol.54 (5): 881–8. PMID9804623.
Cervera P, Tirard M, Barron S, et al. (2002). „Immunohistological localization of the myelinating cell-specific receptor LP(A1).”. Glia38 (2): 126–36. DOI:10.1002/glia.10054. PMID11948806.
Hama K, Bandoh K, Kakehi Y, et al. (2002). „Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.”. FEBS Lett.523 (1-3): 187–92. DOI:10.1016/S0014-5793(02)02976-9. PMID12123830.
Van Leeuwen FN, Olivo C, Grivell S, et al. (2003). „Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.”. J. Biol. Chem.278 (1): 400–6. DOI:10.1074/jbc.M210151200. PMID12393875.
Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H (2004). „Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.”. J. Cell. Sci.116 (Pt 10): 1969–80. DOI:10.1242/jcs.00397. PMID12668728.
Shida D, Kitayama J, Yamaguchi H, et al. (2003). „Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.”. Cancer Res.63 (7): 1706–11. PMID12670925.
Matsuda A, Suzuki Y, Honda G, et al. (2003). „Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.”. Oncogene22 (21): 3307–18. DOI:10.1038/sj.onc.1206406. PMID12761501.
Xu J, Lai YJ, Lin WC, Lin FT (2004). „TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.”. J. Biol. Chem.279 (11): 10459–68. DOI:10.1074/jbc.M311891200. PMID14688263.
Komuro Y, Watanabe T, Kitayama J, et al. (2004). „The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.”. Hepatogastroenterology50 (54): 1770–3. PMID14696401.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs.”. Nat. Genet.36 (1): 40–5. DOI:10.1038/ng1285. PMID14702039.
Kaneider NC, Lindner J, Feistritzer C, et al. (2005). „The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.”. FASEB J.18 (11): 1309–11. DOI:10.1096/fj.03-1050fje. PMID15208267.
„Lysophospholipid Receptors: LPA1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03.